Patents by Inventor Michael Wade

Michael Wade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170308528
    Abstract: Systems and methods for efficiently processing electronically stored information (ESI) are described. The systems and methods describe processing ESI in preparation for, or association with, litigation. The invention preserves the contextual relationships among documents when processing and indexing data, allowing for increased precision and recall during data analytics.
    Type: Application
    Filed: May 5, 2017
    Publication date: October 26, 2017
    Inventors: Michael Wade, Robert Nelson
  • Patent number: 9797682
    Abstract: A target marking system includes a light source configured to emit a beam of thermal radiation and to impinge the beam onto a target. The system also includes a detector configured to collect radiation passing from the target to the detector along a path. The radiation passing from the target in response to impingement of the beam onto the target. The system further includes an optics assembly disposed optically upstream of the detector along the path. The optics assembly includes at least one of an afocal power changer, a camera objective, a catadioptric lens, and a zoom system configured to condition the radiation passing from the target to the detector.
    Type: Grant
    Filed: August 22, 2016
    Date of Patent: October 24, 2017
    Assignee: LaserMax, Inc.
    Inventors: Susan Houde-Walter, William Robert Houde-Walter, Daniel J. Balonek, Brian L. Olmsted, Michael Wade Allen
  • Publication number: 20170234650
    Abstract: A target marking system includes a light source configured to emit a beam of thermal radiation and to impinge the beam onto a target. The system also includes a detector configured to collect radiation passing from the target to the detector along a path. The radiation passing from the target in response to impingement of the beam onto the target. The system further includes an optics assembly disposed optically upstream of the detector along the path. The optics assembly includes at least one of an afocal power changer, a camera objective, a catadioptric lens, and a zoom system configured to condition the radiation passing from the target to the detector.
    Type: Application
    Filed: August 22, 2016
    Publication date: August 17, 2017
    Applicant: Lasermax, Inc.
    Inventors: Susan Houde-Walter, William Robert Houde-Walter, Daniel J. Balonek, Brian L. Olmsted, Michael Wade Allen
  • Patent number: 9713599
    Abstract: The present invention describes novel methods for using Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof, for the treatment and/or prevention of ischemic lesions, such as digital ulcers, in subjects with scleroderma (including systemic sclerosis), Buerger's disease, Raynaud's disease, Raynaud's phenomenon and/or other conditions that cause such lesions. The invention also relates to kits for treatment and/or prevention of ischemic lesions, comprising an effective amount of Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 24, 2015
    Date of Patent: July 25, 2017
    Assignee: United Therapeutics Corporation
    Inventor: Michael Wade
  • Patent number: 9659013
    Abstract: Systems and methods for efficiently processing electronically stored information (ESI) are described. The systems and methods describe processing ESI in preparation for, or association with, litigation. The invention preserves the contextual relationships among documents when processing and indexing data, allowing for increased precision and recall during data analytics.
    Type: Grant
    Filed: November 4, 2014
    Date of Patent: May 23, 2017
    Assignee: PLANET DATA SOLUTIONS
    Inventors: Michael Wade, Robert Nelson
  • Publication number: 20160370145
    Abstract: A target marking system includes a light source emitting a thermal beam and an optics assembly directing the thermal beam to impact a target, the target directing radiation to the optics assembly in response to the impact. The target marking system further includes a detector, and an optics assembly optically connected to the detector.
    Type: Application
    Filed: August 8, 2016
    Publication date: December 22, 2016
    Applicant: Lasermax, Inc.
    Inventors: Susan Houde-Walter, William Robert Houde-Walter, Daniel J. Balonek, Brian L. Olmsted, Michael Wade Allen
  • Patent number: 9448039
    Abstract: A target marking system includes a light source emitting a thermal beam and an optics assembly directing the thermal beam to impact a target, the target directing radiation to the optics assembly in response to the impact. The target marking system further includes a detector, and an optics assembly optically connected to the detector.
    Type: Grant
    Filed: September 23, 2015
    Date of Patent: September 20, 2016
    Assignee: LaserMax, Inc.
    Inventors: Susan Houde-Walter, Daniel Joseph Balonek, Michael Wade Allen, William R. Houde-Walter, Brian L. Olmsted
  • Patent number: 9423214
    Abstract: A target marking system includes a light source configured to emit a beam of thermal radiation and to impinge the beam onto a target. The system also includes a detector configured to collect radiation passing from the target to the detector along a path. The radiation passing from the target in response to impingement of the beam onto the target. The system further includes an optics assembly disposed optically upstream of the detector along the path. The optics assembly includes at least one of an afocal power changer, a camera objective, a catadioptric lens, and a zoom system configured to condition the radiation passing from the target to the detector.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: August 23, 2016
    Assignee: Lasermax Inc.
    Inventors: Susan R. Houde-Walter, Daniel Joseph Balonek, Michael Wade Allen, William R. Houde-Walter, Brian L. Olmsted
  • Patent number: 9287648
    Abstract: A contact element (1) for providing an electrical contact between a first electrical device (7) and a second electrical device, wherein the contact element (1) comprises a first contact portion (2) to be electrically connected to the first electrical device (7) and a second contact portion (4) to be connected to the second electrical device. The first contact portion (2) is arranged at a distance (D) to the second contact portion (4), whereby the contact element (1) comprises further an adjustment portion (3) connecting said first and second contact portion (2, 4), wherein with said adjustment portion (3) said distance (D) between the first contact portion (2) and the second contact portion (4) is adjustable.
    Type: Grant
    Filed: December 9, 2011
    Date of Patent: March 15, 2016
    Assignee: Multi-Holding AG
    Inventors: Brian Wade Mills, Lee Michael Wade, Dustin Delmar Reede Carver, Ian McKay Pratt
  • Publication number: 20160010951
    Abstract: A target marking system includes a light source emitting a thermal beam and an optics assembly directing the thermal beam to impact a target, the target directing radiation to the optics assembly in response to the impact. The target marking system further includes a detector, and an optics assembly optically connected to the detector.
    Type: Application
    Filed: September 23, 2015
    Publication date: January 14, 2016
    Applicant: LaserMax, Inc.
    Inventors: Susan Houde-Walter, Daniel Joseph Balonek, Michael Wade Allen, William R. Houde-Walter, Brian L. Olmsted
  • Patent number: 9199908
    Abstract: This invention pertains generally to prostacyclin formulations and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: December 1, 2015
    Assignee: United Therapeutics Corporation
    Inventors: Ken Phares, David Mottola, Roger Jeffs, Michael Wade
  • Patent number: 9165139
    Abstract: A method for generating a secure application is described herein. The method can include the steps of obtaining a target application and decomposing the target application into original files that contain predictable instructions. One or more predictable instructions in the original files may be identified. In addition, the target application may be modified to create the secure application by binding one or more intercepts to the target application. These intercepts can enable the modification of the predictable instructions in accordance with one or more policies such that the behavior of the secure application is different from the original behavior of the target application. Modification of the target application may be conducted without access to the source code of the target application.
    Type: Grant
    Filed: May 12, 2015
    Date of Patent: October 20, 2015
    Assignee: OPENPEAK INC.
    Inventors: Christopher Michael Wade, Danilo Tan, John R. Brown, Paul Krzyzanowski, Daniel Gittleman, Robert M. Dare
  • Patent number: 9135418
    Abstract: A method for generating a secure application is described herein. The method can include the steps of obtaining a target application and decomposing the target application into original files that contain predictable instructions. One or more predictable instructions in the original files may be identified. In addition, the target application may be modified to create the secure application by binding one or more intercepts to the target application. These intercepts can enable the modification of the predictable instructions in accordance with one or more policies such that the behavior of the secure application is different from the original behavior of the target application. Modification of the target application may be conducted without access to the source code of the target application.
    Type: Grant
    Filed: February 25, 2014
    Date of Patent: September 15, 2015
    Assignee: OPENPEAK INC.
    Inventors: Christopher Michael Wade, Danilo Tan, John R. Brown, Paul Krzyzanowski, Daniel Gittleman, Robert M Dare
  • Publication number: 20150254457
    Abstract: A method for generating a secure application is described herein. The method can include the steps of obtaining a target application and decomposing the target application into original files that contain predictable instructions. One or more predictable instructions in the original files may be identified. In addition, the target application may be modified to create the secure application by binding one or more intercepts to the target application. These intercepts can enable the modification of the predictable instructions in accordance with one or more policies such that the behavior of the secure application is different from the original behavior of the target application. Modification of the target application may be conducted without access to the source code of the target application.
    Type: Application
    Filed: May 12, 2015
    Publication date: September 10, 2015
    Inventors: Christopher Michael Wade, Danilo Tan, John R. Brown, Paul Krzyzanowski, Daniel Gittleman, Robert M. Dare
  • Publication number: 20150246078
    Abstract: The application is directed to a method for treating or preventing vasculopathy comprising administrating to a subject in need thereof a pharmaceutical composition comprising mesenchymal precursor cells (MPCs) and a prostacyclin. Also provided a method for treating or preventing vasculopathy in a subject in need thereof, comprising administering to the subject a prostacyclin and a mesenchymal stem cell (MSC) or a MSC-conditioned culture medium or administering to the subject a MSC or a MSC-conditioned culture medium that has treated with prostacyclin. Pharmaceutical compositions suitable for such treatments are also provided.
    Type: Application
    Filed: July 30, 2013
    Publication date: September 3, 2015
    Applicant: United Therapeutics Corporation
    Inventors: Roger Jeffs, Thomas Petersen, Roger M. Ilagan, Michael Wade
  • Publication number: 20150216909
    Abstract: The current application is directed to a method for treating pulmonary arterial hypertension (PAH), comprising: providing isolated endothelial progenitor cells (EPCs); treating the EPCs with prostacyclin, wherein the treated EPCs exhibit a by perproliferative phenotype with enhanced angiogenic property; and administering a composition comprising the treated EPCs into a subject suffering from PAH.
    Type: Application
    Filed: July 30, 2013
    Publication date: August 6, 2015
    Applicant: United Therapeutics Corporation
    Inventors: Roger Jeffs, Thomas Petersen, Roger M. Ilagan, Michael Wade
  • Patent number: 9062932
    Abstract: A target marking system includes a light source emitting a thermal beam and an optics assembly directing the thermal beam to impact a target, the target directing radiation to the optics assembly in response to the impact. The target marking system further includes a detector, and an optics assembly optically connected to the detector.
    Type: Grant
    Filed: October 12, 2011
    Date of Patent: June 23, 2015
    Assignee: LaserMax, Inc.
    Inventors: Susan Houde-Walter, Daniel Joseph Balonek, Michael Wade Allen, William R. Houde-Walter, Brian L. Olmsted
  • Publication number: 20150164834
    Abstract: The present invention describes novel methods for using Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof, for the treatment and/or prevention of ischemic lesions, such as digital ulcers, in subjects with scleroderma (including systemic sclerosis), Buerger's disease, Raynaud's disease, Raynaud's phenomenon and/or other conditions that cause such lesions. The invention also relates to kits for treatment and/or prevention of ischemic lesions, comprising an effective amount of Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 24, 2015
    Publication date: June 18, 2015
    Applicant: United Therapeutics Corporation
    Inventors: Gilles Cloutier, James Crow, Michael Wade, Richard E. Parker, James E. Loyd
  • Patent number: 9038540
    Abstract: An apparatus and method of launching and retrieving a ballistically launched delivery device. A replaceable bullet trap with an axial cavity may be inserted into a launch delivery tube. The launch delivery tube may be attached to a ballistic muzzle. A projectile may be fired from the ballistic muzzle through the delivery tube and into the axial cavity of the replaceable bullet trap. An impulse and momentum of mass of the projectile may be transferred from the projectile to the replaceable bullet trap and then to the launch delivery tube to launch the launch delivery tube from the ballistic muzzle.
    Type: Grant
    Filed: January 10, 2013
    Date of Patent: May 26, 2015
    Assignee: Cardinal Scientific, Inc.
    Inventors: Andrew Paul Brosky, Michael Wade Broome, Brian Kelly Gallion, Charles Edmund Hebert
  • Publication number: 20150113506
    Abstract: A system and method of adaptively loading a target application is described herein. The method can include the steps of loading an encapsulation application into memory in which the encapsulation application encapsulates the target application and allocating memory for the encapsulated target application. The method can also include the steps of remapping the encapsulated target application into the allocated memory such that the target application is loaded in the memory and configuring the target application to enable calls of the target application to be intercepted by the encapsulation application.
    Type: Application
    Filed: March 12, 2014
    Publication date: April 23, 2015
    Inventor: Christopher Michael Wade